EMDR therapy tested to ease trauma in parents of NICU babies
NCT ID NCT07471321
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a therapy called EMDR can reduce post-traumatic stress symptoms in parents whose baby was in the neonatal intensive care unit (NICU). About 80 parents with PTSD symptoms will be randomly assigned to get EMDR right away or after a waiting period. The goal is to see if EMDR helps lower their distress and improve well-being.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older * Presence of post-traumatic stress symptoms * Eligible to receive EMDR therapy according to clinical assessment * Ability to understand study procedures and provide informed consent * Sufficient proficiency in the Finnish language to complete study assessments and participate in therapy Exclusion Criteria: * Acute psychiatric condition requiring immediate specialized treatment (e.g., acute psychosis or severe suicidal crisis). * Severe cognitive impairment or neurological condition that would prevent participation in psychotherapy or completion of study assessments. * Ongoing trauma-focused psychotherapy at the time of enrollment. * Any condition judged by the investigator to interfere with safe participation in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stress disorders, post-traumatic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kuopio University Hospital
Kuopio, 70211, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cramming PTSD therapy into a few weeks help veterans cut substance use?
- Can targeting guilt ease PTSD in veterans?
- Can a silent word ease both PTSD and chronic pain? a VA trial puts mantram repetition to the test
- Smartphones and fitbits may help veterans with PTSD rethink cannabis use
- Online course aims to boost mental health for teens leaving foster care
- Brain test could match PTSD veterans to the right medication